Stock BVNRY BAVARIAN NORDIC A/S
Add to a list
To use this feature you must be a member
Log inSign up

All News Bavarian Nordic A/S OTC Markets

Equities

BVNRY

US0717711099

Market Closed - OTC Markets
Other stock markets
 13:10:50 2024-05-17 EDT 		5-day change 1st Jan Change
8.648 USD +3.25% Intraday chart for Bavarian Nordic A/S +11.94% -1.11%
05-08 Transcript : Bavarian Nordic A/S, Q1 2024 Earnings Call, May 08, 2024
05-08 Bavarian Nordic A/S Provides Earnings Guidance for the Year 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Bavarian Nordic A/S, Q1 2024 Earnings Call, May 08, 2024
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
GL
Bavarian Nordic A/S : Interim Results (Q1) as of 31 March 2024
PU
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
GL
Bavarian Nordic A/S Provides Earnings Guidance for the Year 2024
CI
Bavarian Nordic A/S Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine
MT
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve
GL
Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve
CI
Bavarian Nordic Starts US Rolling Submission Process for Chikungunya Vaccine Candidate
MT
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
GL
Bavarian Nordic A/S Initiates Rolling Submission of Biologics License Application with FDA for Chikungunya Vaccine Candidate
CI
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS
AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S
GL
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine
AQ
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GL
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
AQ
Bavarian Nordic A/S : Notice Convening Annual General Meeting
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAVA Stock
  4. BVNRY Stock
  5. News Bavarian Nordic A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW